Skip to main content

Table 3 Top 10 hsa-miR-182-5p-related differentially expressed genes in ovarian cancer tissues compared with normal ovarian tissues according to data from Gene Expression Omnibus (GSE14407)

From: Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis

DEGlogFCP.Valueadj. P.Value
up-regulated genes
 MECOM4.9023339719.81E-081.99E-05
 TFAP2A4.7459184351.88E-086.04E-06
 DEPDC14.0329464435.66E-093.03E-06
 AIF1L3.8684119823.79E-089.54E-06
 BIRC53.77360428.61E-093.89E-06
 BCL11A3.5340297361.11E-061.13E-04
 L1CAM3.2792555111.66E-061.49E-04
 HMMR3.2629072452.33E-061.95E-04
 NCAPG3.2293449031.07E-084.36E-06
 DTL3.2086824351.51E-103.76E-07
down-regulated genes
 PDE7B−5.0319302776.84E-093.37E-06
 TCEAL7−4.9288687984.70E-092.66E-06
 DCN−4.8869658871.16E-084.61E-06
 GPM6A−4.7997799352.81E-087.77E-06
 PGR−4.3457638422.85E-087.83E-06
 PPM1E−4.2709225391.43E-085.13E-06
 TMOD2−4.1082611225.21E-107.49E-07
 NKX3–1−3.8513437551.34E-072.48E-05
 TACC1−3.7455496265.00E-081.18E-05
 FGF13−3.6849685382.31E-091.78E-06
  1. DEG differentially expressed gene, FC fold-change